HealthSouth Corp. (NYSE:HLS) had its target price lifted by Lazard Capital Markets from $34.00 to $36.00 in a research note released on Wednesday morning, ARN reports. They currently have a buy rating on the stock.
HealthSouth Corp. (NYSE: HLS) traded up 4.20% on Wednesday, hitting $33.28. HealthSouth Corp. has a 1-year low of $19.85 and a 1-year high of $31.94. The stock’s 50-day moving average is currently $30.03. The company has a market cap of $2.903 billion and a price-to-earnings ratio of 17.89.
A number of other analysts have also recently weighed in on HLS. Analysts at Zacks downgraded shares of HealthSouth Corp. from an outperform rating to a neutral rating in a research note to investors on Monday, July 1st. They now have a $32.30 price target on the stock. Analysts at Deutsche Bank raised their price target on shares of HealthSouth Corp. from $26.50 to $27.50 in a research note to investors on Monday, April 29th. They now have a hold rating on the stock.
Five analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has an average rating of Buy and a consensus target price of $31.14.
HealthSouth Corporation (NYSE: HLS) is an owner and operator of inpatient rehabilitation hospitals.